Inflammatory cytokines in eyes with uveal melanoma and relation with macrophage infiltration
- PMID: 20538984
- PMCID: PMC3261048
- DOI: 10.1167/iovs.10-5526
Inflammatory cytokines in eyes with uveal melanoma and relation with macrophage infiltration
Abstract
Purpose: The presence of an inflammatory phenotype, characterized by an increased expression of HLA antigens and an immunologic infiltrate, carries a bad prognosis in uveal melanoma. This study was conducted to determine whether the aqueous humor (AqH) from eyes with uveal melanoma contains inflammatory cytokines and whether their presence is associated with inflammation.
Methods: Immediately after enucleation, AqH was obtained from 37 eyes containing uveal melanoma. Samples were stored at -80°C until use. Fifteen different cytokines were measured with a multiplex bead array. Intratumoral macrophages were analyzed by immunohistochemistry and immunofluorescence staining. The presence of specific cytokines was compared with histopathologic, genetic, and clinical tumor characteristics, as well as patient survival.
Results: Several cytokines showed significantly higher expression in the AqH of uveal melanoma-containing eyes than in the AqH of eyes undergoing cataract surgery. MCP-3 was associated with the presence of CD68(+) macrophages. Correlations were found between some cytokine levels and a few known prognostic factors of uveal melanoma, but cytokine levels were not of predictive value for survival.
Conclusions: Uveal melanoma-containing eyes often carry increased levels of inflammation-related cytokines in their AqH. However, the presence of most specific cytokines was not related to the presence of macrophages, clinical or histopathologic parameters, or prognosis.
Figures


Similar articles
-
Uveal melanoma: the inflammatory microenvironment.J Innate Immun. 2012;4(5-6):454-62. doi: 10.1159/000334576. Epub 2012 Feb 1. J Innate Immun. 2012. PMID: 22302072 Free PMC article. Review.
-
Cytokines and chemokines in the vitreous fluid of eyes with uveal melanoma.Invest Ophthalmol Vis Sci. 2012 Oct 1;53(11):6748-55. doi: 10.1167/iovs.12-10123. Invest Ophthalmol Vis Sci. 2012. PMID: 22930720
-
Intraocular activation of angiogenic and inflammatory pathways in uveal melanoma.Retina. 2012 Jul;32(7):1373-84. doi: 10.1097/IAE.0b013e318239e299. Retina. 2012. PMID: 22418780
-
Analysis of inflammatory cells in uveal melanoma after prior irradiation.Invest Ophthalmol Vis Sci. 2013 Jan 14;54(1):360-9. doi: 10.1167/iovs.12-9424. Invest Ophthalmol Vis Sci. 2013. PMID: 23211827
-
[Clinically unexpected malignant melanomas of the uvea. 1981-1995, Erlangen Ophthalmopathologic Laboratory/D].Klin Monbl Augenheilkd. 1997 Aug;211(2):118-21. doi: 10.1055/s-2008-1035107. Klin Monbl Augenheilkd. 1997. PMID: 9379637 Review. German.
Cited by
-
Interleukins and cytokine biomarkers in uveitis.Indian J Ophthalmol. 2020 Sep;68(9):1750-1763. doi: 10.4103/ijo.IJO_564_20. Indian J Ophthalmol. 2020. PMID: 32823391 Free PMC article. Review.
-
IL-18 regulates melanoma VLA-4 integrin activation through a Hierarchized sequence of inflammatory factors.J Invest Dermatol. 2014 Feb;134(2):470-480. doi: 10.1038/jid.2013.342. Epub 2013 Aug 12. J Invest Dermatol. 2014. PMID: 23938462
-
Uveal melanoma: the inflammatory microenvironment.J Innate Immun. 2012;4(5-6):454-62. doi: 10.1159/000334576. Epub 2012 Feb 1. J Innate Immun. 2012. PMID: 22302072 Free PMC article. Review.
-
The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo.Theranostics. 2017 Apr 3;7(6):1447-1462. doi: 10.7150/thno.17451. eCollection 2017. Theranostics. 2017. PMID: 28529629 Free PMC article.
-
Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy.Graefes Arch Clin Exp Ophthalmol. 2018 Feb;256(2):411-420. doi: 10.1007/s00417-017-3834-3. Epub 2017 Nov 7. Graefes Arch Clin Exp Ophthalmol. 2018. PMID: 29116399
References
-
- Gragoudas ES, Egan KM, Seddon JM, et al. Survival of patients with metastases from uveal melanoma. Ophthalmology. 1991;98:383–389 - PubMed
-
- Virgili G, Gatta G, Ciccolallo L, et al. Survival in patients with uveal melanoma in Europe. Arch Ophthalmol. 2008;126:1413–1418 - PubMed
-
- Mooy CM, De Jong PT. Prognostic parameters in uveal melanoma: a review. Surv Ophthalmol. 1996;41:215–228 - PubMed
-
- Prescher G, Bornfeld N, Hirche H, et al. Prognostic implications of monosomy 3 in uveal melanoma. Lancet. 1996;347:1222–1225 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous